113 related articles for article (PubMed ID: 758875)
1. Malignant melanoma. Delayed hypersensitivity skin testing.
Roses DF; Campion JF; Harris MN; Gumport SL
Arch Surg; 1979 Jan; 114(1):35-8. PubMed ID: 758875
[TBL] [Abstract][Full Text] [Related]
2. Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
Mavligit GM; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1976 Oct; 57(4):749-51. PubMed ID: 1003526
[TBL] [Abstract][Full Text] [Related]
3. Recall skin-test antigens and the prognosis of stage I melanoma.
Aranha GV; McKhann CF; Simmons RL; Grage TB
J Surg Oncol; 1979; 11(1):13-6. PubMed ID: 431077
[TBL] [Abstract][Full Text] [Related]
4. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
[TBL] [Abstract][Full Text] [Related]
5. Immunologic aspects of unknown primary melanoma.
Giuliano AE; Moseley HS; Irie RF; Golub SH; Morton DL
Surgery; 1980 Jan; 87(1):101-5. PubMed ID: 7350713
[TBL] [Abstract][Full Text] [Related]
6. [Skin reactions of delayed hypersensitivity in melanoblastoma].
Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
8. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
[TBL] [Abstract][Full Text] [Related]
9. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
Camacho ES; Pinsky CM; Braun DW; Golbey RB; Fortner JG; Wanebo HJ; Oettgen HF
Cancer; 1981 May; 47(10):2446-50. PubMed ID: 7272900
[TBL] [Abstract][Full Text] [Related]
10. Effects of murine tumors on delayed hypersensitivity to dinitrochlorobenzene. I. Description of anergy caused by transplanted tumors.
Jessup JM; Cohen MH; Tomaszewski MM; Felix EL
J Natl Cancer Inst; 1976 Nov; 57(5):1077-84. PubMed ID: 1003543
[TBL] [Abstract][Full Text] [Related]
11. Immunological responsiveness in patients with bladder cancer.
Fahey JL; Brosman S; Dorey F
Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
[TBL] [Abstract][Full Text] [Related]
12. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Burdick JF; Wells SA; Herberman RB
Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
[TBL] [Abstract][Full Text] [Related]
13. Skin tests with autologous cholesteryl hemisuccinate-treated tumor cells, DNCB and PPD and their relationship to prognosis in malignant melanoma patients.
Munzarová M; Mechl Z; Kovarík J; Kolcová V
Neoplasma; 1988; 35(2):229-34. PubMed ID: 3374711
[TBL] [Abstract][Full Text] [Related]
14. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
[TBL] [Abstract][Full Text] [Related]
15. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
Lee YT; Sparks FC; Eilber FR; Morton DL
Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
[TBL] [Abstract][Full Text] [Related]
16. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
[TBL] [Abstract][Full Text] [Related]
18. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune competence in patients with prostatic carcinoma.
Stefani SS; Menon M; Canning JR; Clark SS
J Urol; 1978 Oct; 120(4):431-4. PubMed ID: 702665
[TBL] [Abstract][Full Text] [Related]
20. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
